249 related articles for article (PubMed ID: 16966066)
1. Comments and controversies: magnetic resonance spectroscopy and gliomas.
Fan G
Cancer Imaging; 2006 Sep; 6(1):113-5. PubMed ID: 16966066
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy.
Zeng Q; Liu H; Zhang K; Li C; Zhou G
Magn Reson Imaging; 2011 Jan; 29(1):25-31. PubMed ID: 20832225
[TBL] [Abstract][Full Text] [Related]
3. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation.
Toyooka M; Kimura H; Uematsu H; Kawamura Y; Takeuchi H; Itoh H
Clin Imaging; 2008; 32(4):251-8. PubMed ID: 18603178
[TBL] [Abstract][Full Text] [Related]
4. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
[TBL] [Abstract][Full Text] [Related]
7. [Brain tumors: interest of magnetic resonance spectroscopy for the diagnosis and the prognosis].
Sabatier J; Ibarrola D; Malet-Martino M; Berry I
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 1):858-62. PubMed ID: 11677409
[TBL] [Abstract][Full Text] [Related]
8. [Contribution of magnetic resonance spectrometry to the diagnosis of intracranial tumors].
Galanaud D; Nicoli F; Le Fur Y; Roche P; Confort-Gouny S; Dufour H; Ranjeva JP; Peragut JC; Viout P; Cozzone PJ
Ann Med Interne (Paris); 2002 Dec; 153(8):491-8. PubMed ID: 12610422
[TBL] [Abstract][Full Text] [Related]
9. Response to article "Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors".
Sijens PE
Acta Radiol; 2010 Apr; 51(3):326-8. PubMed ID: 20192894
[No Abstract] [Full Text] [Related]
10. [Magnetic resonance spectroscopy in gliomas].
Galanaud D; Chinot O; Metellus P; Cozzone P
Bull Cancer; 2005 Apr; 92(4):327-31. PubMed ID: 15888389
[TBL] [Abstract][Full Text] [Related]
11. Bilateral thalamic glioma.
Douis H; Jafri M; Sherlala K
Arch Neurol; 2008 Dec; 65(12):1666-7. PubMed ID: 19064757
[No Abstract] [Full Text] [Related]
12. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
13. Monovoxel 1H magnetic resonance spectroscopy in the progression of gliomas.
Alimenti A; Delavelle J; Lazeyras F; Yilmaz H; Dietrich PY; de Tribolet N; Lövblad KO
Eur Neurol; 2007; 58(4):198-209. PubMed ID: 17823533
[TBL] [Abstract][Full Text] [Related]
14. Spectrum separation resolves partial-volume effect of MRSI as demonstrated on brain tumor scans.
Su Y; Thakur SB; Karimi S; Du S; Sajda P; Huang W; Parra LC
NMR Biomed; 2008 Nov; 21(10):1030-42. PubMed ID: 18759383
[TBL] [Abstract][Full Text] [Related]
15. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
Tedeschi G; Lundbom N; Raman R; Bonavita S; Duyn JH; Alger JR; Di Chiro G
J Neurosurg; 1997 Oct; 87(4):516-24. PubMed ID: 9322842
[TBL] [Abstract][Full Text] [Related]
16. Partially parallel MR spectroscopic imaging of gliomas at 3T.
Ozturk E; Banerjee S; Majumdar S; Nelson SJ
Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():493-6. PubMed ID: 17945589
[TBL] [Abstract][Full Text] [Related]
17. The value of proton MR-spectroscopy in the differentiation of brain tumours from non-neoplastic brain lesions.
Aydin H; Sipahioğlu S; Oktay NA; Altin E; Kizilgöz V; Hekimoglu B
JBR-BTR; 2011; 94(1):1-10. PubMed ID: 21466053
[TBL] [Abstract][Full Text] [Related]
18. Independent component analysis to proton spectroscopic imaging data of human brain tumours.
Pulkkinen J; Häkkinen AM; Lundbom N; Paetau A; Kauppinen RA; Hiltunen Y
Eur J Radiol; 2005 Nov; 56(2):160-4. PubMed ID: 16233889
[TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopic imaging in the border zone of gliomas: correlation of metabolic and histological changes at low tumor infiltration--initial results.
Stadlbauer A; Nimsky C; Buslei R; Pinker K; Gruber S; Hammen T; Buchfelder M; Ganslandt O
Invest Radiol; 2007 Apr; 42(4):218-23. PubMed ID: 17351427
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of cerebral glioma with advanced magnetic resonance techniques].
Graça J; Palma T; Pereira P; Medina P; Ribeiro C; Evangelista P
Acta Med Port; 2003; 16(3):117-23. PubMed ID: 12868389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]